Breaking news:

$2 Billion Expansion By J&J in North Carolina Facility

Johnson & Johnson on August 21, 2025, went on to announce that it will be adding another 160,000 ft.² dedicated manufacturing facility in its...

Adaptive RCTs: Transforming Clinical Trials for Efficiency

Randomised controlled trials (RCTs) have long been the gold standard of clinical trials, with the most robust evidence of safety and effectiveness of new medicines. But the...

Popular:

Automated Fluid Transfer in Biomanufacturing Systems

Automation in Fluid Transfer: From Manual to Modular Systems...

Smart Drug Delivery Systems Redefine Healthcare Innovation

Smart Drug Delivery Systems: Emerging Market Trends Driven by technical...

Articles

Authors

Interviews

Trend Forecasting: Insights from Dr. Oliver...

Dr. Oliver Okle is a product and service manager...

Jason Shuris of Indero on the...

Jason Shuris is the Chief Business Officer at Indero,...

Executive Interview Series with datma CEO...

datma is a leading provider of federated Real-World Data...

Ethical AI Investment: The Key to...

In this exclusive interview, World Pharma Today sits down...

Pharmaceutical Documentation Enters a New Era...

The future of pharmaceutical documentation is here - faster,...

White Papers

BioPharma

Press Releases

PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery

PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with...

Receptor.AI Announces Collaboration with Sareum to Accelerate Discovery of BBB-Permeable TYK2/JAK1 Inhibitors for Neuroinflammatory Diseases

London, UK — August 14, 2025 — Receptor.AI, an AI- and technology-driven drug discovery company, today announced a strategic collaboration with Sareum Holdings plc (AIM: SAR), a...

Global healthcare AI experts and former UK Health Minister back AI that detects healthcare-associated infections up to 72 hours earlier

Sanome’s MEMORI becomes the first UK‑built, Certified Class IIb Software-as-a-Medical Device for real-time infection prediction, ahead of NHS rollout and FDA approval. AI tool that spots hospital...

Agilent and Tata Institute of Fundamental Research, Hyderabad collaborate to advance scientific frontiers in health and metabolism research

In a significant step toward strengthening India’s efforts in nutrition and metabolism research, Agilent Technologies and the Tata Institute of Fundamental Research (TIFR), Hyderabad have announced a...

Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA

Sino Biological US, Inc. proudly unveils ProPure™, an industry-leading line of ultra-pure, endotoxin-free recombinant proteins, fully produced in the USA at its state-of-the-art Center for Bioprocessing (C4B)...

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to...

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety...

Subscribe

- Gain full access to our premium content

- Never miss a story with active notifications

- Browse free from any location or device.

Industry Reports

The Way Forward for the Healthcare Data Ecosystem

The transformation of worldwide healthcare by way of digital...

Pharma Sector Reactions to US-EU Trade Framework Deal

The United States and the EU have, on August...

Events

swop 2025 - Shanghai World of Packaging

  • Shanghai New International Expo Center (SNIEC), China

  • Nov 25 - Nov 27, 2025

Drug Devlopment

Packaging & Labelling

Manufacturing

More News

Quantum BioPharma Teams for Oral Lucid-MS Drug Formulation

Quantum BioPharma has gone ahead and signed an agreement with a leading CDMO to manufacture oral Lucid-MS Drug formulation, which is a potential breakthrough drug in the...

Bionova Scientific Opens US pDNA Development Facility

The 10,000 ft.² Woodlands site is located near Houston in Texas and is going to design, develop, and even manufacture research-grade plasmid DNA -  pDNA materials in...

Healing Naturally: Exploring Alternative Rehabilitation Methods for Substance Abuse

Substance abuse is a pervasive issue that affects millions of individuals globally, often leading to devastating personal and societal consequences. According to the World Health Organisation, approximately...

Eli Lilly Advocates Reforms for Drug Pricing in the US

In one of the forward-looking statements published on 14 August 2025, Eli Lilly has reaffirmed its commitment to keeping the country right at the forefront when it...

Technology

The Way Forward for the Healthcare Data Ecosystem

The transformation of worldwide healthcare by way of digital...

Real-World Data in Managing Pharmaceutical Efficacy-Effectiveness Gap

The pharmaceutical sector stands at a very critical crossroads...

Quantum Computing Advances Make Way for Lifesaving Therapies

The fact is that there is something very profoundly...

Videos